Skip to main content
VCbacked
Log inGet Started

pixlbio (formerly DefiniGEN)

Cambridge, United Kingdom

Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.

$136K raised
Nov 2024
Undisclosed
BiotechnologyHealth CareLife SciencePharmaceutical

Top Investors

Business Growth Fund24 HaymarketParkwalk AdvisorsUniversity of Cambridge EnterpriseJonathan Milner

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about pixlbio (formerly DefiniGEN)

How much funding has pixlbio (formerly DefiniGEN) raised?
pixlbio (formerly DefiniGEN) has raised $136K in total funding. The most recent round was Undisclosed. The last funding was announced in November 2024.
Who are pixlbio (formerly DefiniGEN)'s investors?
pixlbio (formerly DefiniGEN)'s investors include Business Growth Fund, 24 Haymarket, Parkwalk Advisors, University of Cambridge Enterprise, Jonathan Milner.
Where is pixlbio (formerly DefiniGEN) headquartered?
pixlbio (formerly DefiniGEN) is headquartered in Cambridge, United Kingdom.
What does pixlbio (formerly DefiniGEN) do?
Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.
What stage is pixlbio (formerly DefiniGEN) at?
pixlbio (formerly DefiniGEN) is at the Undisclosed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"pixlbio (formerly DefiniGEN) — Funding & Investors." VCBacked, November 28, 2024, https://www.vcbacked.co/company/pixlbio-formerly-definigen. Accessed July 3, 2026.
APA
VCBacked. (2024). pixlbio (formerly DefiniGEN) — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/pixlbio-formerly-definigen
Wikipedia (cite web)
{{cite web |title=pixlbio (formerly DefiniGEN) — Funding & Investors |url=https://www.vcbacked.co/company/pixlbio-formerly-definigen |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K